AVITA Medical, Inc. (NASDAQ:RCEL – Get Rating) Director Michael S. Perry sold 150,000 shares of the firm’s stock in a transaction on Monday, November 21st. The stock was sold at an average price of $7.18, for a total transaction of $1,077,000.00. Following the completion of the sale, the director now directly owns 229,543 shares in the company, valued at approximately $1,648,118.74. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
AVITA Medical Stock Up 0.3 %
Shares of AVITA Medical stock opened at $7.20 on Thursday. The firm has a market cap of $180.22 million, a PE ratio of -6.05 and a beta of 1.22. AVITA Medical, Inc. has a 12-month low of $4.41 and a 12-month high of $14.87. The company’s fifty day simple moving average is $5.54 and its two-hundred day simple moving average is $5.77.
Institutional Investors Weigh In On AVITA Medical
A number of large investors have recently modified their holdings of the stock. Simplex Trading LLC boosted its stake in shares of AVITA Medical by 2,093.3% during the 1st quarter. Simplex Trading LLC now owns 3,597 shares of the company’s stock valued at $30,000 after purchasing an additional 3,433 shares in the last quarter. Russell Investments Group Ltd. bought a new stake in shares of AVITA Medical during the 1st quarter valued at about $30,000. Amalgamated Bank bought a new stake in shares of AVITA Medical during the 1st quarter valued at about $34,000. Granahan Investment Management LLC boosted its stake in shares of AVITA Medical by 18.6% during the 1st quarter. Granahan Investment Management LLC now owns 25,782 shares of the company’s stock valued at $219,000 after purchasing an additional 4,050 shares in the last quarter. Finally, Rhumbline Advisers boosted its stake in shares of AVITA Medical by 23.3% during the 1st quarter. Rhumbline Advisers now owns 22,913 shares of the company’s stock valued at $194,000 after purchasing an additional 4,326 shares in the last quarter. Institutional investors own 20.75% of the company’s stock.
AVITA Medical Company Profile
AVITA Medical, Inc operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo.
- Get a free copy of the StockNews.com research report on AVITA Medical (RCEL)
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Three CBD Stocks to Dominate a Budding Industry
- Institutional Support for Analog Devices Remains High
- Microsoft Shares: Is it Time to Back Up the Truck?
- Is the 60/40 Portfolio Mix Still in Vogue?
Receive News & Ratings for AVITA Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA Medical and related companies with MarketBeat.com's FREE daily email newsletter.